The Valley Desk

NCT03706040 · Interventional trial

A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

Overall registry status Completed

Phase 2

Conditions Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov